VIRAL CLEARANCE means it works - connecting the dotsFrom the Press Release:
“This is the validation of our Ivectosol™ technology that we were looking for in its direct application to stop the replication of the targeted COVID-19 variants,” stated Dennis Hancock, President and CEO of Mountain Valley MD. “Knowing that Ivectosol™ has viral clearance effect on the three targeted variants we tested in the strictest lab environment in the world provides us with the confidence to pursue immediate human applications. We plan to progress quickly into phase one human trials to support our vision for broad adoption and to also provide necessary and urgent support for the most disadvantaged communities globally.”
What this means? Well, for starters, Bangladesh, as a UN Least Developed Country, is allowed to produce any patented medicine without prior permission under World Trade Organization agreements. They already produce Gilead’s Remdisivir through Eskayef Pharmaceuticals which exports pharma products in Europe, America and Africa. Eskayef is the first among eight Bangladeshi companies allowed to produce the drug after the US Food and Drug Administration issued an Emergency Use Authorization for Remdesivir. MVMD had announced on March 16th in their Bangladesh trials press release “The Company is finalizing
production supply agreements with key Bangladesh pharmaceutical partners to produce
its Ivectosol™ 1% for use and distribution throughout Bangladesh and as a production
hub for broader global distribution.
Reports from c19early.com reveal that Ivermectin showed a 74% improvement in 18,447 patients across 56 studies versus a 24% improvement in 23,349 patients across 15 studies for Remdisivir. In other words Ivermectin is more than twice as effective in treating Covid, and that doesn't factor in MVMD’s IVECTOSOL which has 800% increase in absorption rate in its solubilized state versus standard Ivermectin.
Reports have also recently come out of India that suggest that Remdesivir may soon be dropped from the Indian Council of Medical Research’s Covid treatment protocol, as experts have questioned its effectiveness in Covid treatment. The Centre said it is monitoring the supply of drugs such as Remdesivir, Ivermectin and Favipiravir, essential for treating moderate to critical Covid patients. The Centre said it had ramped up production of these drugs and imported them in large quantities to ensure uninterrupted supply. The Centre added that it will increase the production of Ivermectin, a Covid protocol drug, by five times, from 15 million 12 Mg tabs last month to 77 million this month.
Think for a moment, if MVMD's Ivectosol requires only 1/8th of the dose of a standard dose of Ivermectin, and it produces greater results, what would be the motivation NOT to go with our technology? Think it's a coincidence that we're in Bangladesh?
It's only a matter of time folks. Pay day will come fast. The most rewarding part is knowing we're helping save lives.
Sources:
https://www.globenewswire.com/news-release/2021/05/18/2231755/0/en/Mountain-Valley-MD-Receives-Successful-Results-From-BSL-4-COVID-19-Clearance-Trial-on-Three-Variants-Tested-With-Ivectosol.html https://www.newswire.ca/news-releases/mountain-valley-md-confirms-800-increase-in-ivermectin-absorption-with-solubilization-technology-in-pre-clinical-trial-885662622.html https://wap.business-standard.com/article/health/amid-concerns-over-effectiveness-govt-ramping-up-remdesivir-production-121051900818_1.html https://c19early.com